The impact of atezolizumab and bevacizumab in hepatocellular carcinoma with activated ß-catenin signaling

angiogenesis, HCC, immunotherapy, response, ß-catenin

Saved in:
Bibliographic Details
Main Authors: Krug, Sebastian (Author) , Roth, Laura (Author) , Hämmerle, Monika (Author) , Rosendahl, Jonas (Author) , Kleeff, Jörg H. (Author) , Michl, Patrick (Author)
Format: Article (Journal)
Language:English
Published: 2022
In: Cancer reports
Year: 2022, Volume: 5, Issue: 3, Pages: 1-4
ISSN:2573-8348
DOI:10.1002/cnr2.1493
Online Access:Resolving-System, kostenfrei: http://dx.doi.org/10.1002/cnr2.1493
Get full text
Author Notes:Sebastian Krug, Laura Mattheis, Monika Haemmerle, Jonas Rosendahl,Joerg Kleeff, Patrick Michl
Description
Summary:angiogenesis, HCC, immunotherapy, response, ß-catenin
Item Description:Online veröffentlich am 26. Juli 2021
Physical Description:Online Resource
ISSN:2573-8348
DOI:10.1002/cnr2.1493